These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23177640)

  • 1. Cost-effectiveness treatment strategies for stone disease for the practicing urologist.
    Hyams ES; Matlaga BR
    Urol Clin North Am; 2013 Feb; 40(1):129-33. PubMed ID: 23177640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economics of stone management.
    Lotan Y; Pearle MS
    Urol Clin North Am; 2007 Aug; 34(3):443-53. PubMed ID: 17678993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness.
    Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
    J Urol; 2013 Mar; 189(3):935-9. PubMed ID: 23017509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economics of stone disease.
    Canvasser NE; Alken P; Lipkin M; Nakada SY; Sodha HS; Tepeler A; Lotan Y
    World J Urol; 2017 Sep; 35(9):1321-1329. PubMed ID: 28108799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economics and cost of care of stone disease.
    Lotan Y
    Adv Chronic Kidney Dis; 2009 Jan; 16(1):5-10. PubMed ID: 19095200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs.
    Raheem OA; Khandwala YS; Sur RL; Ghani KR; Denstedt JD
    Eur Urol Focus; 2017 Feb; 3(1):18-26. PubMed ID: 28720363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic aspects of the treatment of urinary stones. Results of the German Society for Shock Wave Lithotripsy].
    Volkmer BG; Petschl S; Chaussy C; Köhrmann KU; Haupt G; Jocham D
    Urologe A; 2009 Oct; 48(10):1214-21. PubMed ID: 19585097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological trends in urolithiasis: impact on our health care systems.
    Trinchieri A
    Urol Res; 2006 Apr; 34(2):151-6. PubMed ID: 16440192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost containment in urology.
    Koch MO; Smith JA
    Urology; 1995 Jul; 46(1):14-24; discussion 24-6. PubMed ID: 7604475
    [No Abstract]   [Full Text] [Related]  

  • 10. European Association of Urology Urolithiasis Guidelines: Where Are We Going?
    Tzelves L; Türk C; Skolarikos A
    Eur Urol Focus; 2021 Jan; 7(1):34-38. PubMed ID: 33011151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical and medical/urologic approaches in acute and chronic urologic stone disease.
    Tseng TY; Stoller ML
    Med Clin North Am; 2011 Jan; 95(1):169-77. PubMed ID: 21095420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical approach to metabolic evaluation and treatment of the recurrent stone patient.
    Bandi G; Nakada SY; Penniston KL
    WMJ; 2008 Apr; 107(2):91-100. PubMed ID: 18593084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panel on cost-effectiveness in health and medicine recommendations: identifying costs.
    Manning WG
    J Clin Psychiatry; 1999; 60 Suppl 3():54-6; discussion 57-8. PubMed ID: 10073379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
    Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
    J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and cost-effectiveness studies in urologic oncology using large administrative databases.
    Wang Y; Mossanen M; Chang SL
    Urol Oncol; 2018 Apr; 36(4):213-219. PubMed ID: 29500134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urologic Clinics of North America. Multidisciplinary management of urinary stone disease. Preface.
    Shah O
    Urol Clin North Am; 2013 Feb; 40(1):xiii. PubMed ID: 23177643
    [No Abstract]   [Full Text] [Related]  

  • 17. Urologic Clinics of North America. Multidisciplinary management of urinary stone disease. Foreword.
    Taneja SS
    Urol Clin North Am; 2013 Feb; 40(1):xi. PubMed ID: 23177642
    [No Abstract]   [Full Text] [Related]  

  • 18. The economics of cardiovascular disease in the United States.
    Chen J; Rizzo JA
    Crit Care Clin; 2012 Jan; 28(1):77-88, vi. PubMed ID: 22123100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease.
    Jaff MR; Cahill KE; Yu AP; Birnbaum HG; Engelhart LM
    Ann Vasc Surg; 2010 Jul; 24(5):577-87. PubMed ID: 20579582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers.
    Teutsch SM; Murray JF
    Am J Manag Care; 1999 Mar; 5(3):301-5. PubMed ID: 10351026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.